SEAGULL HEALTH
Your health,We care!
Sunvozertinib features broad-spectrum inhibition, wild-type selectivity, excellent pharmacokinetic properties and definite clinical benefits, and it stands as a representative of domestic innovations in this field.
AuthenticGuaranteeFast DeliveryPrivacy For the administration of Sunvozertinib in special populations, the dosage regimen should be adjusted based on individual conditions, with a key focus···【Read More】
Update: 27 Jan,2026Source: Haiou HealthViews: 82
Sunvozertinib is a targeted therapy drug for lung cancer with specific gene mutations. Key considerations for its use include strict adherence to medi···【Read More】
Update: 27 Jan,2026Source: Haiou HealthViews: 77
Sunvozertinib is a targeted therapy agent indicated for specific gene mutations (e.g., EGFR exon20ins), primarily used in the treatment of non-small c···【Read More】
Update: 27 Jan,2026Source: Haiou HealthViews: 80
Sunvozertinib is an oral targeted therapy indicated for the treatment of specific subtypes of non-small cell lung cancer (NSCLC), such as those with E···【Read More】
Update: 27 Jan,2026Source: Haiou HealthViews: 79
Sunvozertinib is an oral targeted therapeutic agent for specific gene mutations, whose active ingredient inhibits the abnormal activity of two protein···【Read More】
Update: 27 Jan,2026Source: Haiou HealthViews: 80
Sunvozertinib is a targeted therapy agent indicated for the treatment of specific subtypes of non-small cell lung cancer (NSCLC). Concomitant use of t···【Read More】
Update: 27 Jan,2026Source: Haiou HealthViews: 75
Copyright 2024 @ haiouhealth.com All right reserved SEAGULL HEALTH
